Jacobs Levy Equity Management
RXDX

Jacobs Levy Equity Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Jacobs Levy Equity Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-133,831
Closed -$7.9M – 1069
2022
Q3 		$7.9M Buy
+133,831
New +$7.9M 0.06% 303